Hints and tips:
Related Special Reports
...The company is aiming to develop a wide range of drugs and use its manufacturing scale to stay ahead of pharmaceutical rivals seeking to profit from consumer “hype” for weight loss products, he added....
...Zealand’s products in development will have to compete with the popular Wegovy and Zepbound drugs already on the market and made by Novo Nordisk and Eli Lilly respectively, which suppress appetite....
...It represents a major increase in power for Hassabis, who joined Google when it bought his start-up in 2014, and who now controls much of its AI development and product output....
...It already made its diagnostics products in the country but had “limited manufacturing for pharma”, he added....
...“We are putting a product into 2027, when there is not much other product coming out,” Mistry said, adding that the deal marked a “‘dramatic increase” in Citadel’s London footprint....
...Developing new antibiotics is often unattractive for pharmaceutical companies, as research and development costs are high but their use is designed to be limited to reduce the risk of the product driving...
...While money from Covid vaccine sales is a key driver of the dispute, the patent battle could prove influential for the development of future mRNA-based products....
...AstraZeneca is a specialist in cancer treatments, making $17bn and 37 per cent of sales from oncology products in 2023....
...“It will encourage them to make sure the medicines are available here and it’s a route for people to get tested with the new medicines in development.”...
...Daiichi Sankyo, which developed the drug with AstraZeneca and leads on marketing of the product in the UK, said it was “extremely disappointed by the decision”....
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...Jeff Emmick, Eli Lilly’s senior vice-president of product development, said that while as many as 80mn US adults may suffer from obstructive sleep apnoea, about a quarter of whom face more serious symptoms...
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
...Their emphasis below: During the current business cycle, we believe real gross domestic product (GDP)i growth could accelerate to 7% per year on average, surpassing that of any year since 1950....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...“But the elegant synthetic design of cresomycin, based on an intuitive rationale, provides an exciting scaffold for further development.”...
...make up the backbone of pharmaceutical care....
...The global contract development and manufacturing market, which supports pharma companies in making products and running clinical trials, is projected to grow from $72bn to $90bn over the next two years,...
...But she said believed new entrants would be able to break into the market “if the product is sufficiently differentiated”....
...Lex has been watching the development of this market closely....
...But Eli Lilly declined to say how much of the product would be available in Britain, or which pharmacies will stock the product. Patients in Northern Ireland will not have access to the pen....
...Zealand expects 10 per cent royalties from any eventual sales of the product....
...“The issue affects anyone developing antifungal drugs because regulatory requirements make the development time for human medicines much longer than for agricultural chemicals,” said Birch....
...In-house chip development will give the equipment makers more control in programming the features and performances they wish to have, further differentiating their products from competitors....
...The idea of so-called molecular factories harnesses the basic machinery of sustaining life, in which cells constantly turn out biochemical products....
International Edition